TrialTargeted oncology2019

MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer.

Alexios Matikas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.